Showing 3,161 - 3,180 results of 20,793 for search '"therapy"', query time: 0.14s Refine Results
  1. 3161

    Early empiric anti-Mycobacterium tuberculosis therapy for sepsis in sub-Saharan Africa: a protocol of a randomised clinical trial by Mark Conaway, David R Boulware, Scott K Heysell, Stellah G Mpagama, Christopher C Moore, Alphonce Liyoyo, Conrad Muzoora, Catherine Gitige, Bibie Said, Edwin Nuwagira, Rinah Arinaitwe, Rhina Mushagara, Peter Buzaare, Anna Chongolo, Samuel Jjunju, Precious Twesigye, Megan Null, Tania A Thomas

    Published 2022-06-01
    “…Accordingly, this multisite randomised clinical trial aims to determine whether immediate and/or increased dose anti-TB therapy improves 28-day mortality for participants with HIV and sepsis in Tanzania or Uganda.Methods and analysis This is a phase 3, multisite, open-label, randomised controlled clinical 2×2 factorial superiority trial of (1) immediate initiation of anti-TB therapy and (2) sepsis-specific dose anti-TB therapy in addition to standard of care antibacterials for adults with HIV and sepsis admitted to hospital in Tanzania or Uganda. …”
    Get full text
    Article
  2. 3162
  3. 3163
  4. 3164
  5. 3165

    Cognitive-Behavioral Therapy versus Other PTSD Psychotherapies as Treatment for Women Victims of War-Related Violence: A Systematic Review by N. Inès Dossa, Marie Hatem

    Published 2012-01-01
    “…The subgroup analysis shows that cognitive processing therapy (CPT), culturally adapted CPT, and narrative exposure therapy (NET) contribute to the reduction of PTSD and depression severity in the population of interest. …”
    Get full text
    Article
  6. 3166
  7. 3167

    Successful Treatment of Disseminated Subcutaneous Panniculitis-Like T-Cell Lymphoma with Single Agent Oral Cyclosporine as a First Line Therapy by Nida Iqbal, Vinod Raina

    Published 2014-01-01
    “…Currently there are no standardized therapies for SPTL; however good responses have been seen with chemotherapy regimens generally employed for B-cell lymphomas. …”
    Get full text
    Article
  8. 3168
  9. 3169

    ChatGPT, Google, or PINK? Who Provides the Most Reliable Information on Side Effects of Systemic Therapy for Early Breast Cancer? by Stefan Lukac, Sebastian Griewing, Elena Leinert, Davut Dayan, Benedikt Heitmeir, Markus Wallwiener, Wolfgang Janni, Visnja Fink, Florian Ebner

    Published 2024-12-01
    “…For this purpose, the drugs were divided into three groups: chemotherapy, targeted therapy, and endocrine therapy. The reference for the comparison was the prescribing information of the respective drug. …”
    Get full text
    Article
  10. 3170

    Cost-Effectiveness of Bariatric Surgery versus Medication Therapy for Obese Patients with Type 2 Diabetes in China: A Markov Analysis by Bin Wan, Nan Fang, Wei Guan, Haixia Ding, Ying Wang, Xin Ge, Hui Liang, Xin Li, Yiyang Zhan

    Published 2019-01-01
    “…In the base case analysis, bariatric surgery was more effective and less costly than medication therapy. Over a 40-year time horizon, the mean discounted costs were 86,366.55 RMB per surgical therapy patient and 113,235.94 CNY per medication therapy patient. …”
    Get full text
    Article
  11. 3171
  12. 3172
  13. 3173
  14. 3174
  15. 3175
  16. 3176

    Evaluation of the implementation of personalised outcomes forecasts to optimise supervised exercise therapy in patients with intermittent claudication: a multimethods process evaluation by Philip J van der Wees, Anneroos Sinnige, Thomas J Hoogeboom, Laura H M Marcellis, Andrew Kittelson, Steffie Spruijt, Joep A W Teijink, Anne G E van Bergen

    Published 2025-01-01
    “…Background Personalised outcomes forecasts (POFs) were introduced among physical and exercise therapists in the Netherlands to optimise supervised exercise therapy for patients with intermittent claudication. …”
    Get full text
    Article
  17. 3177

    Antimicrobial Therapy as a Risk Factor of Multidrug-Resistant Acinetobacter Infection in COVID-19 Patients Admitted to the Intensive Care Unit by P. Mihalov, J. Hodosy, A. Koščálová, M. Čaprnda, M. Kachlíková, J. Jurenka, M. Bendžala, P. Sabaka

    Published 2023-01-01
    “…Prior exposure to ceftriaxone (odds ratio (OR) 4.1; 95% confidence interval (CI) 1.4–11.9; P<0.05), tocilizumab therapy (OR 4.7; 95% CI 1.3–15.0; P< 0.05), and ICU length of stay exceeding 11 days (OR 3.7; 95% CI 1.3–10.3; P< 0.05) were independent predictors of MDR-Ab infection. …”
    Get full text
    Article
  18. 3178
  19. 3179
  20. 3180